Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbohydrate-deficient glycoprotein syndromes.

J Kościelak1

  • 1Department of Biochemistry, Institute of Hematology and Blood Transfusion, Warszawa, Poland. kosci@atos.warman.com.pl

Acta Biochimica Polonica
|March 4, 2000
PubMed
Summary

Carbohydrate-deficient glycoprotein syndromes (CDGS) are rare genetic disorders affecting multiple systems, often impacting the nervous system. Diagnosis relies on identifying hypoglycosylation of serum transferrin, a key biochemical marker.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical modifications of alpha1,6-fucosyltransferase define amino acid residues of catalytic importance.

Biochimie·2003
Same author

Band 3 glycoprotein and glycophorin A from erythrocytes of children with congenital disorder of glycosylation type-Ia are underglycosylated.

Proteomics·2001
Same author

Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III.

British journal of haematology·2001
Same author

ABH blood group active glycoconjugates from human red cells.

Transfusion medicine (Oxford, England)·2001
Same author

Neutrophils promote the release of alpha-6-fucosyltransferase from blood platelets through the action of cathepsin G and elastase.

Biochimie·2001
Same author

Glycophorin A in two patients with congenital dyserythropoietic anemia type I and type II is partly unglycosylated.

Acta biochimica Polonica·2001

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology
  • Rare Diseases

Background:

  • Carbohydrate-deficient glycoprotein syndromes (CDGS) are rare, inherited multisystemic disorders.
  • These conditions are characterized by impaired N-linked glycosylation of proteins, leading to significant nervous system dysfunction.
  • Biochemical confirmation, such as detecting hypoglycosylated serum transferrin, is crucial for diagnosis.

Purpose of the Study:

  • To delineate the known clinical and biochemical types of CDGS.
  • To identify the underlying enzymatic or biosynthetic defects responsible for CDGS.
  • To explore potential therapeutic strategies for CDGS.

Main Methods:

  • Clinical and biochemical characterization of CDGS patients.

Related Experiment Videos

  • Enzyme assays to identify deficiencies in glycosylation pathways.
  • Investigation of lipid-oligosaccharide precursor biosynthesis.
  • Genetic analysis for specific CDGS types.

    • Main Results:

    • Six distinct types of CDGS have been identified.
    • Defects in phosphomannomutase, phosphomannose isomerase, alpha-glycosyltransferase, and N-acetylglucosaminyltransferase II are implicated in distinct CDGS types.
    • A variant arises from defective dolichol biosynthesis.
    • Genetic basis is established for only two types.
    • Mannose therapy shows promise for phosphomannose isomerase deficiency.

    Conclusions:

    • CDGS encompass a spectrum of disorders stemming from defects in N-linked protein glycosylation.
    • Further research is expected to uncover additional CDGS variants due to the complexity of glycosylation pathways.
    • Targeted therapies, like mannose supplementation for specific deficiencies, offer therapeutic potential.